Organon

YTD

ALL

Trade Organon 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About OGN

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

CEO

Joseph T. Morrissey

CEOJoseph T. Morrissey

Employees

10,000

Employees10,000

Headquarters

Jersey City, New Jersey

HeadquartersJersey City, New Jersey

Founded

2020

Founded2020

Employees

10,000

Employees10,000

OGN Key Statistics

Market cap

1.86B

Market cap1.86B

Price-Earnings ratio

3.78

Price-Earnings ratio3.78

Dividend yield

4.68%

Dividend yield4.68%

Average volume

4.71M

Average volume4.71M

High today

$7.33

High today$7.33

Low today

$7.12

Low today$7.12

Open price

$7.29

Open price$7.29

Volume

3.18M

Volume3.18M

52 Week high

$17.23

52 Week high$17.23

52 Week low

$6.18

52 Week low$6.18

Stock Snapshot

Organon(OGN) stock is priced at $7.20, giving the company a market capitalization of 1.86B. It carries a P/E multiple of 3.78 and pays a dividend yield of 4.7%.

During the trading session on 2025-12-04, Organon(OGN) shares reached a daily high of $7.33 and a low of $7.12. At a current price of $7.20, the stock is +1.1% higher than the low and still -1.8% under the high.

Trading volume for Organon(OGN) stock has reached 3.18M, versus its average volume of 4.71M.

The stock's 52-week range extends from a low of $6.18 to a high of $17.23.

Analyst ratings

50%

of 8 ratings

Buy

12.5%

Hold

50%

Sell

37.5%

People also own

Based on the portfolios of people who own OGN. This list is generated using Robinhood data, and it’s not a recommendation.